Jessica Hopkins
Dr. Jessica Hopkins is employed at the Dalla Lana School of Public Health at the University of Toronto, McMaster University, and Public Health Ontario. She is also Co-Chair of the Ontario Immunization Advisory Committee (OIAC), and formerly held lead Officer positions for Hamilton and Niagara, and Peel Health Region. She is registered to practice medicine at Limeridge Medical Centre.
Affiliations
Limeridge Medical Centre
Hopkins is registered with the College of Physicians and Physicians (CPSO) to practice medicine at Limeridge Medical Centre in Hamilton, Ontario.1)
McMaster University
Hopkins is an Assistant Professor in Health Research Methods, Evidence and Impact in the Faculty of Health Sciences at McMaster University.2)
Ontario COVID-19 Science Advisory Table
Hopkins is a member of the Ontario COVID-19 Science Advisory Table.3) In this capacity, Hopkins urged parents to inject their children with a COVID-19 product as soon as they were approved by the National Advisory Committee on Immunization (NACI), as well as all of their caregivers.4)
Ontario Medical Association
Hopkins has served as a member on the Physician Services Committee of the Ontario Medical Association, for which she received “remuneration for travel and accommodation”.5)
Public Health Agency of Canada
Hopkins is a member of the Technical Advisory Committee for COVID-19 under the Public Health Agency of Canada (PHAC).6)
Public Health Ontario
Hopkins is the Chief Health Protection and Emergency Preparedness Officer at Public Health Ontario. Her listed areas of expertise are public health, communicable diseases, surveillance and epidemiology, and public health policy. Her COVID-19 research activities under PHO are “examining child and family policies”, “collaborating on understanding mask use in schools through simulation”, and “collaboration on public health syndromic surveillance using people-driven data”.7)
University of Toronto
Hopkins is an Adjunct Lecturer with the Dalla Lana School of Public Health at the University of Toronto, in the Clinical Public Health Division. Her research interests are “applied public health practice and communicable disease control”.8)
Publications
Hopkins' relevant studies featured by her profiles on U of T and McMaster’s websites include:
- Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results.9)
- Conclusion: “Large-scale SARS-CoV-2 screening testing initiatives among low pre-test probability populations [patients who are not symptomatic and/or don’t have a confirmed contact with a person sick with COVID-19] should be evaluated thoroughly prior to implementation given the risk of false positives and consequent potential for harm at the individual and population level.”
- S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 202110)
- The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada11)
- Funded by the Department of Medicine COVID-19 Funding Opportunity from the University of Toronto
- Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy12)
- Commissioned and funded by the World Health Organization (WHO)
- Antivirals for Treatment of Influenza: A Systematic Review and Meta-analysis of Observational Studies13)
- Funded by the World Health Organization (WHO) and McMaster University
- Evaluation of the ability of standardized supports to improve public health response to syndromic surveillance for respiratory diseases in Canada14)
- Funded by the Canadian Institutes of Health Research (CIHR)
- World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen-and-treat strategies to prevent cervical cancer15)
- Funded by the World Health Organization (WHO), Flanders International Cooperation Agency, Institut National du Cancer (National Cancer Institute in France), and Gavi, the Vaccine Alliance